An extension study of JR-031 in infants with neonatal hypoxic ischemic encephalopathy (hereinafter referred to as nHIE) for which hypothermia therapy is indicated

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2033200293

Enrollment

Registered

2021-01-13

Start date

2021-02-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hypoxic ischemic encephalopathy (nHIE)

Interventions

None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: An infant whose parent (legal representative) provides written informed consent

Exclusion criteria

Exclusion criteria: An infant who, in the opinion of the investigator or subinvestigator, is not appropriate for the study

Design outcomes

Primary

Measure	Time frame
Kyoto Scale of Psychological Development 2001	—

Contacts

Public ContactTatsuyoshi Yamamoto

JCR Pharmaceuticals Co., Ltd.

clinical_development@jp.jcrpharm.com+81-797-32-8582

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026